Bayer rises on FY outlook hike
** Shares in Bayer BAYGn.DE rise 2% in early Frankfurt trade after the German pharmaceuticals and agriculture group raised adjusted core earnings outlook for the year on the back of a better-than-expected performance at its pharma division
** Bayer expects adjusted core earnings on a currency-adjusted basis to reach between €9.8-€10.3 billion ($11-$11.5 billion) from a previously expected range of €9.6-€10.1 billion
** "Overall, we expect the results to be well received given the Pharma-driven EBITDA beat and guidance raise," J.P Morgan ("overweight") writes
** Bayer tops the German blue-chip index .GDAXI in early Frankfurt trade
($1 = 0.8937 euros)